Invention Grant
- Patent Title: Minicell based delivery of biologically active compounds
-
Application No.: US14693338Application Date: 2015-04-22
-
Publication No.: US09670270B2Publication Date: 2017-06-06
- Inventor: Roger Sabbadini , Neil Berkley , Mark Surber , Robert Klepper
- Applicant: Vaxiion Therapeutics, LLC
- Applicant Address: US CA San Diego
- Assignee: Vaxiion Therapeutics, LLC
- Current Assignee: Vaxiion Therapeutics, LLC
- Current Assignee Address: US CA San Diego
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12N15/00 ; C12N15/10 ; C12N15/74 ; C12P21/02 ; C40B40/02 ; G01N33/50 ; G01N33/543 ; G01N33/60 ; C12N15/70

Abstract:
Minicells are used to deliver biologically active compounds including radioisotopes, polypeptides, nucleic acids, small molecules, drug molecules, and chemotherapeutic agents. In some cases, the minicell displays ligands or binding moieties that target the minicell to a desired host cell.
Public/Granted literature
- US20150218254A1 MINICELL BASED DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS Public/Granted day:2015-08-06
Information query